RxDoctor Payments Data

Mark Sowell, DPM

Primary Podiatric Medicine · Nacogdoches, TXNPI 1679517528

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Organogenesis Inc. at 51.3% of the total. That places this record below the midpoint for primary podiatric medicine clinicians in TX, where the typical reported total is $1,641.

$209in general payments, 2019–2025

Across 10 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$107
  • Orthofix Medical, Inc.$37
  • Biowound Solutions, Inc.$27
  • Stryker$23
  • Sanara Medtech Inc.$15

What the payments were for

  • Food & beverage$209100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.1$107
Orthofix Medical, Inc.1$37
Biowound Solutions, Inc.5$27
Stryker1$23
Sanara Medtech Inc.2$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$209 in reported general payments places this provider in the 10th percentile of 36 primary podiatric medicine providers in Texas.

See all primary podiatric medicine providers in Texas

Medicare billing

Part B allowed, 2024
$255,471
Medicare patients
396
Services billed
4,384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin50$292
Gabapentin11$87

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Nacogdoches

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →